Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | SIRT2 | Q8IXJ6 | 5/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.50 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL5396593 | 0.92 | KDM4E (0.55) | KDM4EPOLBATMALDH1A1GLA | |
| SCHEMBL30442091 | 0.86 | KDM4E (0.56) | KDM4EPOLBATMALDH1A1GLA | |
| SCHEMBL28027868 | 0.84 | BCAT2 (0.53) | KDM4EPOLBATMALDH1A1GLA | |
| SCHEMBL9921482 | 0.82 | KDM4E (0.56) | KDM4EPOLBALDH1A1SIRT2HPGD | |
| SCHEMBL8628627 | 0.82 | POLB (0.67) | KDM4EPOLBATMALDH1A1GAA | |
| SCHEMBL175535 | 0.82 | KDM4E (0.56) | KDM4EPOLBALDH1A1SIRT2HPGD | |
| SCHEMBL10424663 | 0.82 | SIRT2 (0.62) | KDM4EALDH1A1SIRT2HPGDMAPT | |
| SCHEMBL8061202 | 0.82 | KDM4E (0.47) | KDM4EPOLBATMALDH1A1GLA | |
| SCHEMBL13450268 | 0.82 | KDM4E (0.50) | KDM4EPOLBATMALDH1A1GLA | |
| SCHEMBL8686659 | 0.80 | ALDH1A1 (0.68) | KDM4EPOLBALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3623372-B1 | PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | VALO HEALTH INC (US) | 2026-02-04 | — | — | EP | claimed |
| EP-4568707-A1 | PEPTIDE-BASED DELIVERY AGENT AND METHOD OF MAKING AND USING THE SAME | EndoRel Biosciences LLC (US) | 2025-06-18 | — | — | EP | claimed |
| CN-120076830-A | Peptide-based delivery agents and methods of making and using the same | 恩多雷尔生物科学有限责任公司 | 2025-05-30 | — | — | CN | claimed |
| WO-2024036315-A1 | PEPTIDE-BASED DELIVERY AGENT AND METHOD OF MAKING AND USING THE SAME | ENDOREL BIOSCIENCES LLC (US) | 2024-02-15 | — | — | WO | claimed |
| EP-4121421-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | Novartis AG (CH) | 2023-01-25 | — | — | EP | claimed |
| WO-2021186324-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | NOVARTIS AG (CH) | 2021-09-23 | — | — | WO | claimed |
| CN-107759561-B | O-formamido benzamide compound with insecticidal activity and application thereof | 江苏中旗科技股份有限公司 | 2021-04-02 | — | — | CN | claimed |
| CN-107001325-B | O-formamido benzamide compound and application thereof | 江苏中旗科技股份有限公司 | 2020-06-16 | — | — | CN | claimed |
| CN-105037324-B | O-formammidotiazol-benzamide compounds and its application with insecticidal activity | 江苏中旗科技股份有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-107759561-A | A kind of O-formammidotiazol-benzamide compounds and its application with insecticidal activity | 江苏中旗科技股份有限公司 | 2018-03-06 | — | — | CN | claimed |
| WO-2009027482-A2 | TSH RECEPTOR ANTAGONIZING TETRAHYDROQUINOLINE COMPOUNDS | N.V. ORGANON (NL) | 2009-03-05 | — | — | WO | claimed |
| EP-1942888-A2 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | Cytokinetics, Inc. (US) | 2008-07-16 | — | — | EP | claimed |
| WO-2007056078-A2 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | CYTOKINETICS, INC. (US) | 2007-05-18 | — | — | WO | claimed |
| EP-1114047-B1 | AN IMPROVED PROCESS FOR THE PREPARATION OF THIAZOLIDINE-2,4-DIONE DERIVATIVES | REDDYS LAB LTD DR (IN) | 2003-03-19 | — | — | EP | claimed |
| EP-0750909-B1 | THE USE OF AMINO HYDROGENATED QUINAZOLINE COMPOUNDS AND DERIVATIVES THEREOF FOR ABSTAINING FROM DRUG DEPENDENCE | NANNING MAPLE LEAF PHARMACEUTI (CN) | 2002-12-11 | — | — | EP | claimed |
| WO-2002095393-A2 | DRUG EVOLUTION: DRUG DESIGN AT HOT SPOTS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2002-11-28 | — | — | WO | claimed |
| US-5846975-A | Use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence | NANNING MAPLE LEAF PHARMACEUTICAL CO., LTD. (CN) | 1998-12-08 | — | — | US | claimed |
| EP-0750909-A1 | THE USE OF AMINO HYDROGENATED QUINAZOLINE COMPOUNDS AND DERIVATIVES THEREOF FOR ABSTAINING FROM DRUG DEPENDENCE | NANNING MAPLE LEAF PHARMACEUTICAL CO., LTD. (CN) | 1997-01-02 | — | — | EP | claimed |
| EP-0670855-A1 | NITRO OR NITROSO GROUP TERMINATED MESOGENIC EPOXY RESIN ADDUCTS | THE DOW CHEMICAL COMPANY (US) | 1995-09-13 | — | — | EP | claimed |
| WO-1994012555-A1 | NITRO OR NITROSO GROUP TERMINATED MESOGENIC EPOXY RESIN ADDUCTS | THE DOW CHEMICAL COMPANY (US) | 1994-06-09 | — | — | WO | claimed |